Scorecard
| Current Price | Overvalued | |
| Yield (%) – Higher is better Current Yield: 2.61% Industry Average: 3.28% | ||
| Dividend Growth (%) – Higher is better Dividend Growth: 2.60% Industry Average: 6.41% | ||
| Returns (%) – Higher is better Returns: 13.28% Industry Average: 15.03% | ||
| Free Cash Flow Payout Ratio (%) – Lower is better FCFPR: 40.65% Industry Average: 51.49% | ||
GILEAD SCIENCES, INC.
(XNAS:GILD)
Industry: Pharmaceuticals
| Price | Change (Daily) |
| $ 125.59 | $ -0.28 |
Dividend
Annual Dividend | Annual Yield |
$ 3.28 | 2.61 % |
Dividend Streak | 5 Year Average |
11 year(s) | 3.85 % |
Fair Price
Current Stock price is considered: Overvalued
| Current Price ● $ 125.59 |
| Less Than $76.26 | $76.26 – $112.77 | More Than $112.77 |
| Undervalued | Fair Price | Overvalued |
Using average Dividend Yield for stock valuation. Learn about this method for Fair Price analysis HERE.
Growth
Dividend Growth Rate
1 Year | 3 Year | 5 Year |
2.60 % | 2.67 % | 3.05 % |
| 2021 | 2022 | 2023 | 2024 | 2025 |
| $ 2.84 | $ 2.92 | $ 3.00 | $ 3.08 | $ 3.16 |
Price Return
1 Year | 5 Year | CAGR 5 Years |
$ 14.72 13.28 % | $ 56.73 | 12.77 % |